Product NDC: | 0409-6102 |
Proprietary Name: | Furosemide |
Non Proprietary Name: | FUROSEMIDE |
Active Ingredient(s): | 10 mg/mL & nbsp; FUROSEMIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-6102 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018667 |
Marketing Category: | NDA |
Start Marketing Date: | 19820528 |
Package NDC: | 0409-6102-02 |
Package Description: | 25 VIAL, GLASS in 1 TRAY (0409-6102-02) > 2 mL in 1 VIAL, GLASS |
NDC Code | 0409-6102-02 |
Proprietary Name | Furosemide |
Package Description | 25 VIAL, GLASS in 1 TRAY (0409-6102-02) > 2 mL in 1 VIAL, GLASS |
Product NDC | 0409-6102 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | FUROSEMIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19820528 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | FUROSEMIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |